4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001140361-25-005113
President sold 4,000 shares at an average $12.22 ($48,860)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ma Songjiang President | 2025-02-14 | Sale 10b5-1 | −2,000 | $11.94 | $23,880 | 2,869,260 | I: show line 1 in the form |
| Ma Songjiang President | 2025-02-18 | Sale 10b5-1 | −2,000 | $12.49 | $24,980 | 2,867,260 | I: show line 2 in the form |
| Open-market sales · 4,000 sh · avg $12.22 · $48,860 | |||||||
Loading xslF345X05/form4.xml…